https://orcid.org/0000-0002-1358-7870
Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Giovanny Castellanos, Duván Sebastián Valbuena, Erika Pérez, Victoria E Villegas & Milena Rondón-Lagos. (2023) Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer. Breast Cancer: Targets and Therapy 15, pages 189-211.
Read now
Read now
Kah Min Yap, Mahendran Sekar, Shivkanya Fuloria, Yuan Seng Wu, Siew Hua Gan, Nur Najihah Izzati Mat Rani, Vetriselvan Subramaniyan, Chandrakant Kokare, Pei Teng Lum, M Yasmin Begum, Shankar Mani, Dhanalekshmi Unnikrishnan Meenakshi, Kathiresan V Sathasivam & Neeraj Kumar Fuloria. (2021) Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature. International Journal of Nanomedicine 16, pages 7891-7941.
Read now
Read now
Articles from other publishers (34)
Jessica Pougoue Ketchemen, Hanan Babeker, Anjong Florence Tikum, Anand Krishnan Nambisan, Fabrice Ngoh Njotu, Emmanuel Nwangele & Humphrey Fonge. (2023) Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics. British Journal of Cancer 129:1, pages 153-162.
Crossref
Crossref
Marco Antonio Fonseca-Montaño, Mireya Cisneros-Villanueva, Isabelle Coales & Alfredo Hidalgo-Miranda. (2023) LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer. Frontiers in Genetics 14.
Crossref
Crossref
Sylvain Loric, Jérôme Alexandre Denis, Cédric Desbene, Michèle Sabbah & Marc Conti. (2023) Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management. International Journal of Molecular Sciences 24:8, pages 7208.
Crossref
Crossref
Yedi Herdiana, Nasrul Wathoni, Dolih Gozali, Shaharum Shamsuddin & Muchtaridi Muchtaridi. (2023) Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy. Pharmaceutics 15:3, pages 879.
Crossref
Crossref
Atziri Corin Chavez Alvarez, Chahrazed Bouzriba, Emmanuel Moreau, Philippe Auzeloux, Sophie Besse, Vincent Ouellette, Mitra Zarifi Khosroshahi, Marie-France Côté, Sylvie Pilote, Elisabeth Miot-Noirault, Jean-Michel Chezal, Chantale Simard, René C -Gaudreault & Sébastien Fortin. (2023) Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver Microsomes. Journal of Medicinal Chemistry 66:4, pages 2477-2497.
Crossref
Crossref
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies & Rajesh Singh. (2023) Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer. Cancers 15:4, pages 1320.
Crossref
Crossref
Nandini Verma. 2023. Transcription and Translation in Health and Disease. Transcription and Translation in Health and Disease
49
73
.
Desh Deepak Singh, Hae-Jeung Lee & Dharmendra Kumar Yadav. (2022) Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer. Frontiers in Pharmacology 13.
Crossref
Crossref
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, Davood Kamali, Salar Javanshir, Farzaneh Hasani Sadi, Mehrdad Hashemi, Teimour Tabari, Mohsen Rashidi, Sepideh Mirzaei, Atefeh Zarepour, Ali Zarrabi, Danielle De Greef & Anupam Bishayee. (2022) Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action. Cellular and Molecular Life Sciences 79:11.
Crossref
Crossref
Ivan Budimir, Čedna Tomasović-Lončarić, Kristina Kralik, Josipa Čonkaš, Domagoj Eljuga, Rado Žic, Božo Gorjanc, Hrvoje Tucaković, Doroteja Caktaš, Josip Jaman, Valentino Lisek, Zlatko Vlajčić, Krešimir Martić & Petar Ozretić. (2022) Higher Expressions of SHH and AR Are Associated with a Positive Receptor Status and Have Impact on Survival in a Cohort of Croatian Breast Cancer Patients. Life 12:10, pages 1559.
Crossref
Crossref
Sylvie Rodrigues-Ferreira & Clara Nahmias. (2022) Predictive biomarkers for personalized medicine in breast cancer. Cancer Letters 545, pages 215828.
Crossref
Crossref
Snehal Nirgude, Sagar Desai & Bibha Choudhary. (2022)
Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated
miRNA
/
mRNA
expression analysis
. Cancer Reports 5:10.
Crossref
Crossref
Vineela Parvathaneni, Rameswari Chilamakuri, Nishant S. Kulkarni, Nabeela F. Baig, Saurabh Agarwal & Vivek Gupta. (2022) Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action. International Journal of Molecular Sciences 23:19, pages 11455.
Crossref
Crossref
Lorinda van Dyk, Nicolette J. D. Verhoog & Ann Louw. (2022) Combinatorial treatments of tamoxifen and SM6Met, an extract from Cyclopia subternata Vogel, are superior to either treatment alone in MCF-7 cells. Frontiers in Pharmacology 13.
Crossref
Crossref
Manuel Gámez-Chiachio, David Sarrió & Gema Moreno-Bueno. (2022) Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs. Cancers 14:18, pages 4543.
Crossref
Crossref
Maria Condello, Gloria D’Avack, Enrico Pierluigi Spugnini & Stefania Meschini. (2022) Electrochemotherapy: An Alternative Strategy for Improving Therapy in Drug-Resistant SOLID Tumors. Cancers 14:17, pages 4341.
Crossref
Crossref
Xiang Cui & Min Cui. (2022) Glabridin induces paraptosis-like cell death via ER stress in breast cancer cells. Heliyon 8:9, pages e10607.
Crossref
Crossref
Marwah Suliman Maashi, Mahmood Al-Mualm, Ghaidaa Raheem Lateef Al-Awsi, Maria Jade Catalan Opulencia, Moaed E. Al-Gazally, Bekhzod Abdullaev, Walid Kamal Abdelbasset, Mohammad Javed Ansari, Abduladheem Turki Jalil, Fahad Alsaikhan, Mohammed Nader Shalaby & Yasser Fakri Mustafa. (2022) Apigenin alleviates resistance to doxorubicin in breast cancer cells by acting on the JAK/STAT signaling pathway. Molecular Biology Reports 49:9, pages 8777-8784.
Crossref
Crossref
Liang Ma, Xiaojing Xuan, Minghui Fan, Yumeng Zhang, Guozan Yuan, Guozheng Huang & Zi Liu. (2022) A novel 8-hydroxyquinoline derivative induces breast cancer cell death through paraptosis and apoptosis. Apoptosis 27:7-8, pages 577-589.
Crossref
Crossref
Loredana Bergandi, Umberto Lucia, Giulia Grisolia, Iris Chiara Salaroglio, Iacopo Gesmundo, Riccarda Granata, Romano Borchiellini, Antonio Ponzetto & Francesca Silvagno. (2022) Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models. International Journal of Molecular Sciences 23:14, pages 7955.
Crossref
Crossref
Chompunud Chompunud Na Ayudhya, Potchanapond Graidist & Varomyalin Tipmanee. (2022) Potential Stereoselective Binding of Trans-(±)-Kusunokinin and Cis-(±)-Kusunokinin Isomers to CSF1R. Molecules 27:13, pages 4194.
Crossref
Crossref
Inês Soares de Pinho, Catarina Abreu, Inês Gomes, Sandra Casimiro, Teresa Raquel Pacheco, Rita Teixeira de Sousa & Luís Costa. (2022) Exploring new pathways in endocrine-resistant breast cancer. Exploration of Targeted Anti-tumor Therapy, pages 337-361.
Crossref
Crossref
Sabba Mehmood, Muhammad Faheem, Hammad Ismail, Syeda Mehpara Farhat, Mahwish Ali, Sidra Younis & Muhammad Nadeem Asghar. (2022) ‘Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics’. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Maria Panagopoulou, Andrianna Drosouni, Dionysiοs Fanidis, Makrina Karaglani, Ioanna Balgkouranidou, Nikolaos Xenidis, Vassilis Aidinis & Ekaterini Chatzaki. (2022) ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker. International Journal of Molecular Sciences 23:7, pages 3717.
Crossref
Crossref
Fatima Domenica Elisa De Palma, Francesco Salvatore, Jonathan G. Pol, Guido Kroemer & Maria Chiara Maiuri. (2022) Circular RNAs as Potential Biomarkers in Breast Cancer. Biomedicines 10:3, pages 725.
Crossref
Crossref
Naba Kumar Das & Saptadip Samanta. (2022) The potential anti-cancer effects of melatonin on breast cancer. Exploration of Medicine, pages 112-127.
Crossref
Crossref
Md Sohel, Partha Biswas, Md. Al Amin, Md. Arju Hossain, Habiba Sultana, Dipta Dey, Suraiya Aktar, Arifa Setu, Md. Sharif Khan, Priyanka Paul, Md. Nurul Islam, Md. Ataur Rahman, Bonglee Kim & Abdullah Al Mamun. (2022) Genistein, a Potential Phytochemical against Breast Cancer Treatment-Insight into the Molecular Mechanisms. Processes 10:2, pages 415.
Crossref
Crossref
Phuong Linh Nguyen, Chang Hoon Lee, Heesoon Lee & Jungsook Cho. (2022) Induction of Paraptotic Cell Death in Breast Cancer Cells by a Novel Pyrazolo[3,4-h]quinoline Derivative through ROS Production and Endoplasmic Reticulum Stress. Antioxidants 11:1, pages 117.
Crossref
Crossref
SEMA MISIR, SERAP OZER YAMAN, NINA PETROVIĆ, CEREN SUMER, CEYLAN HEPOKUR & YUKSEL ALIYAZICIOGLU. (2022) circRNAs in drug resistance of breast cancer. Oncology Research 30:4, pages 157-172.
Crossref
Crossref
Freda Halim, Yohana Azhar, Suwarman Suwarman & Bethy Hernowo. (2022) p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer. F1000Research 11, pages 330.
Crossref
Crossref
Freda Halim, Yohana Azhar, Suwarman Suwarman & Bethy Hernowo. (2022) p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer. F1000Research 11, pages 330.
Crossref
Crossref
Dedy Hermansyah, Felix Zulhendri, Conrad O. Perera, Naufal N. Firsty, Kavita Chandrasekaran, Rizky Abdulah, Herry Herman & Ronny Lesmana. (2022) The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers. Integrative Cancer Therapies 21, pages 153473542210968.
Crossref
Crossref
E. A. Bocharova, N. I. Kopytina & Е. Е. Slynko. (2021) Anti-tumour drugs of marine origin currently at various stages of clinical trials (review). Regulatory Mechanisms in Biosystems 12:2, pages 265-280.
Crossref
Crossref
Elif Damla Arisan, Ozge Rencuzogullari, Clara Cieza-Borrella, Francesc Miralles Arenas, Miriam Dwek, Sigrun Lange & Pinar Uysal-Onganer. (2021) MiR-21 Is Required for the Epithelial–Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells. International Journal of Molecular Sciences 22:4, pages 1557.
Crossref
Crossref